These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3210187)

  • 1. Local oestrogen for recurrent epistaxis caused by familial telangiectasia.
    Tombleson PM
    J R Coll Gen Pract; 1988 May; 38(310):227. PubMed ID: 3210187
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid.
    Saba HI; Morelli GA; Logrono LA
    N Engl J Med; 1994 Jun; 330(25):1789-90. PubMed ID: 8190155
    [No Abstract]   [Full Text] [Related]  

  • 3. [Two cases of hereditary hemorrhagic telangiectasia showing rapid improvement of epistaxis after combination therapy of estrogen and progesterone].
    Ito S; Hirono S
    Rinsho Ketsueki; 1982 Aug; 23(8):1205-10. PubMed ID: 7143724
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Sabbà C; Gallitelli M; Palasciano G
    N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
    [No Abstract]   [Full Text] [Related]  

  • 5. Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia.
    Velegrakis GA; Prokopakis EP; Papadakis CE; Helidonis ES
    J Otolaryngol; 1997 Dec; 26(6):384-6. PubMed ID: 9438937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
    Alderman C; Corlett J; Cullis J
    Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid in hereditary hemorrhagic telangiectasia.
    Lozano M
    N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Olitsky SE
    Am J Otolaryngol; 2012; 33(3):375-6. PubMed ID: 22079094
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic telangiectasia.
    Ananthasubramaniam G; Sathyavathi R; Chitra N
    J Assoc Physicians India; 1981 May; 29(5):425-7. PubMed ID: 7298565
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel treatment for patients with hereditary haemorrhagic telangiectasia.
    Farnan TB; Gallagher G; Scally CM
    J Laryngol Otol; 2002 Oct; 116(10):849-50. PubMed ID: 12437844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epistaxis in hereditary haemorrhagic telangiectasia.
    Haitjema T; Balder W; Disch FJ; Westermann CJ
    Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In reference to hereditary hemorrhagic telangiectasia/avastin.
    Bachmann-Harildstad G
    Laryngoscope; 2010 Oct; 120(10):2134. PubMed ID: 20824638
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hemorrhagic telangiectasia: a review of 76 cases.
    Shah RK; Dhingra JK; Shapshay SM
    Laryngoscope; 2002 May; 112(5):767-73. PubMed ID: 12150604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
    Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
    Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Harvey RJ; Kanagalingam J; Lund VJ
    Am J Rhinol; 2008; 22(2):182-7. PubMed ID: 18416977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [I-192 in epistaxis caused by Rendu-Osler disease].
    Gaia F
    Boll Mal Orecch Gola Naso; 1969; 87(5):410-23. PubMed ID: 5399721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.